These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31530543)
1. Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma. Mohammed A; Janakiram NB; Madka V; Zhang Y; Singh A; Biddick L; Li Q; Lightfoot S; Steele VE; Lubet RA; Suen CS; Miller MS; Sei S; Rao CV Cancer Prev Res (Phila); 2019 Nov; 12(11):751-762. PubMed ID: 31530543 [TBL] [Abstract][Full Text] [Related]
2. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Reddy BS; Rao CV; Rivenson A; Kelloff G Carcinogenesis; 1993 Aug; 14(8):1493-7. PubMed ID: 8353834 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512 [TBL] [Abstract][Full Text] [Related]
5. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599 [TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Madka V; Kumar G; Pathuri G; Panneerselvam J; Zhang Y; Ganta V; Lightfoot S; Lubet R; Suen CS; Steele VE; Janakiram NB; Mohammed A; Rao CV Cancer Prev Res (Phila); 2021 Nov; 14(11):1009-1020. PubMed ID: 34341012 [TBL] [Abstract][Full Text] [Related]
7. Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Reddy BS; Wang CX; Kong AN; Khor TO; Zheng X; Steele VE; Kopelovich L; Rao CV Cancer Res; 2006 Apr; 66(8):4542-6. PubMed ID: 16618783 [TBL] [Abstract][Full Text] [Related]
8. Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats. Janakiram NB; Mohammed A; Zhang Y; Brewer M; Bryant T; Lightfoot S; Steele VE; Rao CV Cancer Prev Res (Phila); 2013 Dec; 6(12):1251-61. PubMed ID: 24080207 [TBL] [Abstract][Full Text] [Related]
9. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in beta-cryptoxanthin and hesperidin. Tanaka T; Kohno H; Murakami M; Shimada R; Kagami S; Sumida T; Azuma Y; Ogawa H Int J Cancer; 2000 Oct; 88(1):146-50. PubMed ID: 10962453 [TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Rao CV; Steele VE; Swamy MV; Patlolla JM; Guruswamy S; Kopelovich L Cancer Res; 2009 Oct; 69(20):8175-82. PubMed ID: 19826045 [TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Reddy BS; Kawamori T; Lubet R; Steele V; Kelloff G; Rao CV Carcinogenesis; 1999 Aug; 20(8):1645-8. PubMed ID: 10426822 [TBL] [Abstract][Full Text] [Related]
13. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats. Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105 [TBL] [Abstract][Full Text] [Related]
14. Enhancement by thyroxine of experimental carcinogenesis induced in rat colon by azoxymethane. Iishi H; Tatsuta M; Baba M; Okuda S; Taniguchi H Int J Cancer; 1992 Apr; 50(6):974-6. PubMed ID: 1555896 [TBL] [Abstract][Full Text] [Related]
15. A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Ju J; Hao X; Lee MJ; Lambert JD; Lu G; Xiao H; Newmark HL; Yang CS Cancer Prev Res (Phila); 2009 Feb; 2(2):143-52. PubMed ID: 19155443 [TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Tanaka T; Kojima T; Suzui M; Mori H Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related]
19. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Suzui M; Okuno M; Tanaka T; Nakagama H; Moriwaki H Cancer Lett; 2002 Sep; 183(1):31-41. PubMed ID: 12049812 [TBL] [Abstract][Full Text] [Related]
20. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. Steele VE; Rao CV; Zhang Y; Patlolla J; Boring D; Kopelovich L; Juliana MM; Grubbs CJ; Lubet RA Cancer Prev Res (Phila); 2009 Nov; 2(11):951-6. PubMed ID: 19892664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]